Valvular & structural heart disease

Transcatheter vs Surgical Aortic Valve Replacement in Lower-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials

J Am Coll CardiolPublished Systematic review and meta-analysis of randomised trials

Pooled result · All-cause deathResult — go to the resultHazard ratio 0.80 95% CI 0.66–0.97

Authors' conclusion

In lower-risk patients, TAVR was associated with a reduced hazard of death and death or disabling stroke compared with SAVR, while rates of stroke were equivalent.

Study context

Population
Lower-risk patients with severe AS
Participants
5,341 patients · 6 RCTs
Comparison
Transcatheter aortic valve replacement (TAVR) vs surgical aortic valve replacement (SAVR)
  • TAVRn = 2,717
  • SAVRn = 2,624reference
Outcome
All-cause death
Follow-up
5 years
Methodological detailsreconstructed time-to-event individual participant data (IPD), pooled survival analyses, Weighted mean follow-up 35.7 months
  • Reconstructed time-to-event IPD
  • Pooled survival analyses
  • Weighted mean follow-up 35.7 months

Pooled result

All-cause death

Hazard ratio

0.80

95% CI 0.66–0.97

P = 0.02

TAVR vs SAVR
HR 0.80 (95% CI 0.66–0.97); P = 0.02

As reported in the abstract

Further pooled results

OutcomeHR (95% CI)P value
All-cause death or disabling stroke · 5 years · 19% reduction in hazard · pooled survival analyses of reconstructed time-to-event IPD0.81 (0.68–0.96)P = 0.01

Stroke

No difference in stroke (HR: 0.97; 95% CI: 0.74-1.26)
P = 0.80

Original publication

Transcatheter vs Surgical Aortic Valve Replacement in Lower-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials. J Am Coll Cardiol. Published 11 March 2025. doi:10.1016/j.jacc.2024.12.031

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.